|
aap closed 5% Capital Increase successfully
aap Implantate AG, a medical technology company listed on the Frankfurt stock exchange in the Prime Standard segment, has successfully completed its yesterday announced 5% capital increase. The capital increase was placed in full by an issue of 1,267,357 shares at a price of EUR 2.18 apiece.
Until the registration of the implementation of the capital increase and the listing of the new shares – expected to be effected end of September 2008 – a major shareholder of the company made own shares available by a temporary securities loan for the investors supply.
Subject to the recording of the capital increase in the commercial register the company’s capital will increase by EUR 1,267,357 from the present EUR 25,347,156 to EUR 26,614,513, divided into the same number of registered shares. From the capital increase the company receives more than EUR 2.7, intended to serve the purpose of funding further growth.
For further information, please contact: aap Implantate AG | | Lorenzweg 5 | | D-12099 Berlin | | X | | Oliver Bielenstein | Nanette Hüdepohl | | Director/CFO | Head of Corporate Communications and Legal Affairs | | Tel.: +49 30 750 19 - 140 | Tel.: +49 30 75019 - 133 | | Fax: +49 30 750 19 - 290 | Fax: +49 30 75019 - 290 | | X | | WKN 506660, ISIN DE0005066609 | | Prime Standard/Regulated Market | | Traded at all German Stock Exchanges |
|